DK0610250T3 - Vaccine med porcint reproduktivt respiratorisk syndrom og diagnose heraf - Google Patents
Vaccine med porcint reproduktivt respiratorisk syndrom og diagnose herafInfo
- Publication number
- DK0610250T3 DK0610250T3 DK92920950T DK92920950T DK0610250T3 DK 0610250 T3 DK0610250 T3 DK 0610250T3 DK 92920950 T DK92920950 T DK 92920950T DK 92920950 T DK92920950 T DK 92920950T DK 0610250 T3 DK0610250 T3 DK 0610250T3
- Authority
- DK
- Denmark
- Prior art keywords
- respiratory syndrome
- porcine reproductive
- vaccine
- diagnosis
- reproductive respiratory
- Prior art date
Links
- 230000001850 reproductive effect Effects 0.000 title abstract 2
- 230000000241 respiratory effect Effects 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91202646 | 1991-10-14 | ||
PCT/EP1992/002331 WO1993007898A1 (en) | 1991-10-14 | 1992-10-09 | Porcine reproductive respiratory syndrome vaccine and diagnostic |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0610250T3 true DK0610250T3 (da) | 1996-04-09 |
DK0610250T4 DK0610250T4 (da) | 2009-03-02 |
Family
ID=8207942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92920950T DK0610250T4 (da) | 1991-10-14 | 1992-10-09 | Vaccine med porcint reproduktivt respiratorisk syndrom (PRRS) og diagnose heraf |
Country Status (12)
Country | Link |
---|---|
US (1) | US6033844A (da) |
EP (1) | EP0610250B2 (da) |
JP (1) | JPH07501049A (da) |
AT (1) | ATE131067T1 (da) |
AU (1) | AU2684792A (da) |
CA (1) | CA2121241C (da) |
DE (1) | DE69206631T2 (da) |
DK (1) | DK0610250T4 (da) |
ES (1) | ES2083764T5 (da) |
GR (1) | GR3019112T3 (da) |
HU (1) | HU220113B (da) |
WO (1) | WO1993007898A1 (da) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2103460C (en) * | 1991-06-06 | 2000-09-26 | Gert Wensvoort | Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
US6380376B1 (en) | 1992-10-30 | 2002-04-30 | Iowa State University Research Foundation | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US5695766A (en) * | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US6773908B1 (en) | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US6592873B1 (en) | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
US6251397B1 (en) | 1992-10-30 | 2001-06-26 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same |
ATE197314T1 (de) * | 1993-02-08 | 2000-11-15 | Bayer Ag | Verfahren zum vermehren des das reproduktions- und atemwegs-syndrom verursachenden schweinevirus und dessen verwendung als impfstoff. |
ES2074950B1 (es) * | 1993-09-17 | 1996-03-16 | Iberica Cyanamid | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. |
DE4407489A1 (de) * | 1994-03-07 | 1995-09-14 | Bayer Ag | Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines |
DE69522984T2 (de) * | 1994-04-11 | 2002-04-25 | Akzo Nobel Nv | Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins |
GB2289279B (en) * | 1994-05-13 | 1998-09-16 | Iberica Cyanamid | Diagnostic kits and vaccines containing recombinant PRRSV proteins |
US5690940A (en) * | 1995-06-21 | 1997-11-25 | Regents Of The University Of Minnesota | Low pathogencity PRRS live virus vaccines and methods of preparation thereof |
ES2102971B1 (es) * | 1996-01-25 | 1998-03-01 | Hipra Lab Sa | Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion. |
US5866401A (en) * | 1996-03-01 | 1999-02-02 | Schering Corporation | Porcine reproductive and respiratory syndrome vaccine |
CN1165342C (zh) * | 1996-03-01 | 2004-09-08 | 先灵公司 | 猪生殖和呼吸综合症疫苗 |
DK0835930T3 (da) * | 1996-10-09 | 2001-06-18 | Akzo Nobel Nv | Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV) |
EP0839912A1 (en) | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
DE69837992T2 (de) | 1997-05-06 | 2008-03-20 | Boehringer Ingelheim Vetmedica Gmbh | Prrsv-antigene, die auf peptidsequenzen des prrs-virus basieren, für die verwendung als impfstoff und für diagnostische tests |
UA78180C2 (uk) | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
JP3961222B2 (ja) | 1999-03-08 | 2007-08-22 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | Prrsvワクチン |
CA2370372C (en) | 1999-04-22 | 2009-02-24 | United States Department Of Agriculture | Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
US6740490B2 (en) | 2001-01-29 | 2004-05-25 | Kansas State University Research Foundation | Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding |
US6841364B2 (en) * | 2002-01-22 | 2005-01-11 | Protatek International, Inc. | Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
AR049924A1 (es) * | 2004-06-18 | 2006-09-13 | Univ Minnesota | Identificacion de organismos viralmente infectados y vacunados |
US7632636B2 (en) | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
ES2733428T3 (es) | 2004-12-30 | 2019-11-29 | Boehringer Ingelheim Animal Health Usa Inc | Composiciones inmunogénicas frente a PCV2 y métodos para producir composiciones de este tipo |
RU2007130801A (ru) | 2005-01-13 | 2009-02-20 | Берингер Ингельхайм Ветмедика Гмбх (De) | Улучшенные вакцины против репродуктивно-респираторного синдрома свиней (prrs) |
ES2386973T3 (es) | 2005-06-24 | 2012-09-10 | Regents Of The University Of Minnesota | Virus PRRS, clones infecciosos, mutantes de los mismos, y métodos de utilización |
PL1968630T3 (pl) | 2005-12-29 | 2018-08-31 | Boehringer Ingelheim Vetmedica, Inc. | Multiwalentne immunogenne kompozycje PCV2 |
WO2008013918A2 (en) * | 2006-07-26 | 2008-01-31 | Myelin Repair Foundation, Inc. | Cell cycle regulation and differentiation |
AR064888A1 (es) | 2007-01-12 | 2009-04-29 | Univ Illinois | Celulas no simias para el crecimiento del virus del sindrome reproductor y respiratorio porcino (prrs) |
US7666585B2 (en) * | 2007-06-15 | 2010-02-23 | Protatek International, Inc. | Construction of chimera PRRSV, compositions and vaccine preparations |
US9545438B2 (en) * | 2008-02-29 | 2017-01-17 | Universiteit Gent | Determination of antigenicity of an inactivated virus |
AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
ME02271B (me) | 2011-02-17 | 2016-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Novi evropski prrsv soj |
DK2675476T3 (da) | 2011-02-17 | 2015-12-14 | Boehringer Ingelheim Vetmed | Fremgangsmåde til fremstilling af PRRSV i kommerciel skala |
WO2013017568A1 (en) | 2011-07-29 | 2013-02-07 | Boehringer Ingelheim Vetmedica Gmbh | INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF |
US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
EP2968513A2 (en) | 2013-03-15 | 2016-01-20 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
HUE061768T2 (hu) | 2013-12-20 | 2023-08-28 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus variáns, európai PRRS virus cDNS klón, és alkalmazásuk |
UA124140C2 (uk) | 2015-08-31 | 2021-07-28 | Бьорінгер Інгельхайм Ветмедіка Гмбх | Пестивірусна вакцина проти вродженого тремору поросят |
EP3389706A1 (en) | 2015-12-14 | 2018-10-24 | Boehringer Ingelheim Vetmedica, Inc. | Hybrid core feline vaccines |
CA3136141A1 (en) | 2019-04-04 | 2020-10-08 | Boehringer Ingelheim Animal Health USA Inc. | Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof |
BR112023001324A2 (pt) | 2020-07-24 | 2023-02-14 | Boehringer Ingelheim Animal Health Usa Inc | Combinação de vacina de suíno |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4452902A (en) * | 1981-11-19 | 1984-06-05 | Labsystems Oy | Method and equipment for the measurement of properties of a liquid |
CA2103460C (en) * | 1991-06-06 | 2000-09-26 | Gert Wensvoort | Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
CA2116348C (en) * | 1991-08-26 | 2001-07-03 | James E. Collins | Sirs vaccine and diagnosis method |
CA2076744C (en) * | 1991-08-26 | 2000-06-27 | Danny W. Chladek | Viral agent associated with mystery swine disease |
WO1993006211A1 (en) * | 1991-09-16 | 1993-04-01 | Collins James E | Vaccine for mystery swine disease and method for diagnosis thereof |
DE69522984T2 (de) * | 1994-04-11 | 2002-04-25 | Akzo Nobel Nv | Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins |
-
1992
- 1992-10-09 WO PCT/EP1992/002331 patent/WO1993007898A1/en active IP Right Grant
- 1992-10-09 ES ES92920950T patent/ES2083764T5/es not_active Expired - Lifetime
- 1992-10-09 EP EP19920920950 patent/EP0610250B2/en not_active Expired - Lifetime
- 1992-10-09 AU AU26847/92A patent/AU2684792A/en not_active Abandoned
- 1992-10-09 DK DK92920950T patent/DK0610250T4/da active
- 1992-10-09 HU HU9401056A patent/HU220113B/hu unknown
- 1992-10-09 CA CA 2121241 patent/CA2121241C/en not_active Expired - Fee Related
- 1992-10-09 AT AT92920950T patent/ATE131067T1/de not_active IP Right Cessation
- 1992-10-09 DE DE69206631T patent/DE69206631T2/de not_active Expired - Lifetime
- 1992-10-09 JP JP5507405A patent/JPH07501049A/ja active Pending
-
1996
- 1996-02-27 GR GR960400533T patent/GR3019112T3/el unknown
-
1997
- 1997-05-27 US US08/863,116 patent/US6033844A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK0610250T4 (da) | 2009-03-02 |
CA2121241A1 (en) | 1993-04-29 |
HU9401056D0 (en) | 1994-07-28 |
DE69206631T2 (de) | 1996-05-15 |
US6033844A (en) | 2000-03-07 |
JPH07501049A (ja) | 1995-02-02 |
EP0610250B1 (en) | 1995-12-06 |
HU220113B (hu) | 2001-11-28 |
CA2121241C (en) | 2007-12-04 |
AU2684792A (en) | 1993-05-21 |
HUT69803A (en) | 1995-09-28 |
GR3019112T3 (en) | 1996-05-31 |
WO1993007898A1 (en) | 1993-04-29 |
EP0610250B2 (en) | 2008-10-29 |
ES2083764T3 (es) | 1996-04-16 |
ES2083764T5 (es) | 2009-04-01 |
DE69206631D1 (de) | 1996-01-18 |
ATE131067T1 (de) | 1995-12-15 |
EP0610250A1 (en) | 1994-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0610250T3 (da) | Vaccine med porcint reproduktivt respiratorisk syndrom og diagnose heraf | |
FR07C0073I2 (fr) | Vaccin contre le papillomavirus | |
SE8604007D0 (sv) | Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids) | |
NO871313L (no) | Fremgangsmaate for fremstilling av virusvaksine. | |
DE50214630D1 (de) | Verfahren zur grosstechnischen herstellung von impfstoffen | |
BR0309339A (pt) | Vìrus vaccinia modificado ankara para a vacinação de neonatos | |
DK1183332T3 (da) | Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142 | |
SE9202968D0 (sv) | New peptides, diagnostic antigens, use thereof, vaccines and medicaments | |
KR970706300A (ko) | E형 간염 파키스탄형 균주의 재조합 단백질 및 이를 이용한 진단방법과 백신(recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines) | |
OA09653A (en) | Rubella peptides | |
ES2053477T3 (es) | Vacuna viva para enfermedades contagiosas de pollos. | |
Biedel | Recurrent mumps parotitis following natural infection and immunization | |
EP0250128A3 (en) | Novel virus isolated from patients with aids | |
Freij et al. | A small outbreak of Coxsackie B5 infection with two cases of cardiac involvement and orchitis followed by testicular atrophy | |
Shope et al. | The attenuation of the virus of epizootic hemorrhagic disease of deer by its serial passage in the brains of newborn mice | |
ES2074965B1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
Yang et al. | The cytotoxic effect of human immune sera on Herpesvirus hominis infected cells | |
Krugman | Live attenuated measles vaccine: Its development and characteristics. | |
World Health Organization | Draft agenda: Expert Committee on Smallpox, Geneva, 14-20 January 1964 | |
SU1739559A1 (ru) | Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов |